Study the Antibacterial activity and Immunomodulatory Effect of Aqueous Commiphora myrrh Leaves Extract in vivo
DOI:
https://doi.org/10.51699/cajmns.v6i4.2955Keywords:
Immunomodulatory, Pseudomonas aeruginosa, Commiphora myrrh, aqueous leaves extract, immune response.Abstract
Commiphora myrrh demonstrated antibacterial efficacy against microorganisms. Myrrh stimulates the activation/maturation and differentiation of both (myeloid and lymphoid) cell types of WBCs during wound healing of caused stomach and skin injuries, and it has significant anti-inflammatory, analgesic, and anti-hyperlipidemia efficiency. The aim of this study is to investigate the antibacterial activity and immunomodulatory effect of aqueous C. myrrha extract. Pseudomonas aeruginosa was collected from the Microbiology Laboratory/College of Health and Medical Technology/Sawa University. C myrrh leaves were bought from the Iraqi market and dried for extraction. Concentrations of 25, 50, 75, and 100 mg/ml were created. The experimental design included two parts, in vitro and in vivo. The in vitro investigation estimated the antibacterial activity using the agar diffusion method and in vivo study was Included four groups. Group I (Control) received daily intraperitoneal injections of normal saline. Group II received intraperitoneal injections of 1.5 x 108 CFU/ml of P. aeruginosa. Group III received oral administration of 100 mg/ml extract. Group IV received intraperitoneal injections of 1.5 x 108 CFU/ml of P. aeruginosa followed by oral administration of 100 mg/ml extract for 14 days. then notice the clinical signs of each group followed by estimation , TLR-2 , IL-17 , IL 10 , arthus reaction and delayed hypersensitivity. The extract demonstrated strong antibacterial activity against the tested isolates. The maximum activity was seen at a dose of 100 mg/ml, producing an inhibition zone of 1.6 ± 0.01. The animals in group IV had the highest TLR-2, IL-17, and IL-10 levels with a significant difference (p≤ 0.05).The arthus test and DHT results showed that the group that received a mixture of extract and P. aeurginosa had significantly greater values than the other group (p < 0.05). C. myrrh aqueous extract leaves has immunomodulatory effect on the immune response ,innate immunity and acquired immunity as well as it showed the antibacterial activity in vitro .
References
R. A. Abdul-Ghani, N. Loutfy, and A. Hassan, "Myrrh and trematodoses in Egypt: an overview of safety, efficacy and effectiveness profiles," Parasitol. Int., vol. 58, pp. 210–214, 2009.
G. E. Batiha, L. Wasef, J. O. Teibo, H. M. Shaheen, A. M. Zakariya, O. A. Akinfe, T. K. A. Teibo, H. M. Al-Kuraishy, A. I. Al-Garbee, A. Alexiou, and M. Papadakis, "Commiphora myrrh: a phytochemical and pharmacological update," Naunyn-Schmiedeberg's Arch. Pharmacol., vol. 396, no. 3, pp. 405–420, 2023, doi: 10.1007/s00210-022-02325-0.
M. K. Bhattacharjee and T. Alenezi, "Antibiotic in myrrh from Commiphora molmol preferentially kills nongrowing bacteria," Future Sci. OA, vol. 6, no. 4, p. FSO458, 2020.
D. B. Hana, H. M. Kadhim, G. A. Jasim, and Q. N. Latif, "Antibacterial activity of Commiphora molmol extracts on some bacterial species in Iraq," Sch. Acad. J. Pharm., vol. 5, no. 12, pp. 406–412, 2016.
A. S. A. Haffor, "Effect of myrrh (Commiphora molmol) on leukocyte levels before and during healing from gastric ulcer or skin injury," J. Immunotoxicol., vol. 7, no. 1, pp. 68–75, 2010.
M. A. Shalaby and A. A. E. Hammouda, "Analgesic, anti-inflammatory and anti-hyperlipidemic activities of Commiphora molmol extract (Myrrh)," J. Intercult. Ethnopharmacol., vol. 3, no. 2, pp. 56–62, 2014.
A. J. Fatani, F. S. Alrojayee, M. Y. Parmar, H. M. Abuohashish, M. M. Ahmed, and S. S. Al-Rejaie, "Myrrh attenuates oxidative and inflammatory processes in acetic acid-induced ulcerative colitis," Exp. Ther. Med., vol. 12, no. 2, pp. 730–738, 2016.
J. Y. Shin et al., "Commiphora myrrha inhibits itch-associated histamine and IL-31 production in stimulated mast cells," Exp. Ther. Med., vol. 18, no. 3, pp. 1914–1920, 2019.
X. Ding and J. L. Staudinger, "The ratio of constitutive androstane receptor to pregnane X receptor determines the activity of guggulsterone against the Cyp2b10 promoter," J. Pharmacol. Exp. Ther., vol. 314, no. 1, pp. 120–127, 2005.
W. M. Al-Bishri and O. S. Al-Attas, "Guggul resin extract improve hyperglycemia and lipid profile in streptozotocin induced diabetes mellitus in rats," Life Sci. J., vol. 10, 2013.
T. Shen, G. H. Li, X. N. Wang, and H. X. Lou, "The genus Commiphora: a review of its traditional uses, phytochemistry and pharmacology," J. Ethnopharmacol., vol. 142, no. 2, pp. 319–330, 2012.
A. M. Mohamed and N. S. Metwally, "Antiaflatoxigenic activities of some plant aqueous extracts against aflatoxin-B1 induced renal and cardiac damage," J. Biosci. Med., 2009.
I. Wiegand, K. Hilpert, and R. E. Hancock, "Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances," Nat. Protoc., vol. 3, no. 2, pp. 163–175, 2008.
A. P. Fratzke, A. E. Gregory, E. J. Van Schaik, and J. E. Samuel, "Coxiella burnetii whole cell vaccine produces a Th1 delayed-type hypersensitivity response in a novel sensitized mouse model," Front. Immunol., vol. 12, p. 754712, 2021.
IBM Corp., IBM SPSS Statistics for Windows, Version 22.0, Armonk, NY: IBM Corp., 2013.
D. B. Hana, H. M. Kadhim, G. A. Jasim, and Q. N. Latif, "Antibacterial activity of Commiphora molmol extracts on some bacterial species," unpublished.
J. W. Kim, S. Park, Y. W. Sung, H. J. Song, S. W. Yang, J. Han, … and H. J. Kim, "Evaluation of antibacterial and antiviral compounds from Commiphora myrrha (T. Nees) Engl. resin and their promising application with biochar," Appl. Sci., vol. 13, no. 18, p. 10549, 2023.
S. S. Mahmoud, E. Aly, Z. H. Fahmy, and A. El Shenawy, "Effect of Commiphora molmol (Myrrh) extract on mice infected by Giardia lamblia," J. Biosci. Med., vol. 7, no. 10, pp. 50–56, 2019.
K. M. Ashry and I. M. El-Ashmawy, "Immunological and toxicological effects of Curcuma longa and Commiphora molmol in mice," in Proc. 4th Int. Sci. Conf., Mansoura, Egypt, 2005, vol. 2, pp. 1429–1438.
A. M. Massoud, N. M. El-Kholy, F. A. El-Shennawy, and R. E. Farag, "Study of some immune aspects in patients with fascioliasis before and after Commiphora molmol (Mirazid) treatment," J. Egypt. Soc. Parasitol., vol. 34, pp. 315–332, 2004.
M. M. Abdel-Aziz, A. T. Abbas, and K. A. El-Bakry, "Immune response in mice infected with Schistosoma mansoni and treated with myrrh," J. Med. Sci., vol. 6, pp. 855–861, 2006.
M. S. Kim et al., "Myrrh inhibits LPS-induced inflammatory response and protects from cecal ligation and puncture-induced sepsis," Evid.-Based Complement. Altern. Med., vol. 2012, p. 278718, 2012, doi: 10.1155/2012/278718.
H. J. Park et al., "JNK pathway is involved in the inhibition of inflammatory target gene expression and NF-kappaB activation by melittin," J. Inflamm., vol. 5, pp. 1–13, 2008.
H. Ahmed-Hassan, M. S. Abdul-Cader, M. A. Sabry, E. Hamza, and M. F. Abdul-Careem, "Toll-like receptor (TLR) 4 signalling induces myeloid differentiation primary response gene (MYD) 88 independent pathway in avian species leading to type I interferon production and antiviral response," Virus Res., vol. 256, pp. 107–116, 2018.
Y. Chen et al., "Salvia miltiorrhiza polysaccharide activates T lymphocytes of cancer patients through activation of TLRs mediated-MAPK and NF-κB signaling pathways," J. Ethnopharmacol., vol. 200, pp. 165–173, 2017.
H. Y. Bakir, R. A. Attia, A. E. Mahmoud, and Z. Ibraheim, "m-RNA gene expression of INF-γ and IL-10 during intestinal phase of Trichinella spiralis after myrrh and albendazole treatment," Iran. J. Parasitol., vol. 12, no. 2, pp. 188–194, 2017.
K. A. Elbakry and M. M. Abdelaziz, "Myrrh and artesunate modulate some Th1 and Th2 cytokines secretion in Schistosoma mansoni infected mice," Cent. Eur. J. Immunol., vol. 41, no. 2, pp. 138–142, 2016.
J. H. Krouse, M. J. Derebery, and S. J. Chadwick, Managing the Allergic Patient. Philadelphia, PA: Elsevier Health Sciences, 2008.
